Tissue Engineering Part C Methods · 2013 · 105 citations · 30 references
PharmacyBioengineeringPharmacologyBioavailabilityDrug DeliveryMucosal Drug DeliveryDrug AbsorptionGastrointestinal AbsorptionIntestinal AbsorptionMucosal AbsorptionMucosal PermeabilityDrug PermeabilityDrug Transport Across MucosaDrug Transport Across The Intestinal EpitheliumIntestinal Drug Permeability
Human epithelial cell culture models of monolayer Caco-2 cells have been widely employed to assess the absorption of drug molecules across intestinal mucosa. However, cautions should be taken when interpreting the conclusions from those models due to their undesirable phenotype and functionality when compared with the native intestinal tissue. In the present study, an improved, more physiologically relevant three-dimensional (3D) culture model of the intestinal mucosa was developed to study drug absorption, in which a coculture of epithelial cells, including Caco-2 cells and HT29-methotrexate cells, was indirectly seeded on a Transwell filter insert with collagen gel and stromal cells (fibroblasts and immunocytes) incorporation. This setting-up provided a compatible environment to improve the phenotype and functionality of the epithelial cells. Compared with the monolayer culture of Caco-2 cells, the reconstructed 3D model displayed more physiologically relevant characteristics evidenced by its decreased TEER value and mucus-like layer formation. A decreased expression of P-gp and an increased expression of BCRP were also observed in the current 3D culture model, leading to a changed secretory permeability of their substrates. More importantly, an improved correlation (R(2)=0.843) was obtained between the absorptive permeability across the 3D coculture model and the human absorption fraction especially for those model compounds with moderate or high permeability. Thus, this engineered 3D coculture model presents a unique, improved opportunity to evaluate drug permeability in vitro.
30
Screening for human ADME/Tox drug properties in drug discovery
Albert P. Li · Drug Discovery Today · 2001 · 538 citations
Constanze Hilgendorf, Hildegard Spahn‐Langguth, C G Regårdh et al. · Journal of Pharmaceutical Sciences · 2000 · 469 citations
Gunilla Englund, Fredrik Rorsman, Anders Rönnblom et al. · European Journal of Pharmaceutical Sciences · 2006 · 368 citations
Pharmacy, Biochemistry, Pharmacology +15